JUN and rheumatoid arthritis: The mechanisms of action would mainly be the rebalancing of immune system, inhibition of synovial hyperplasia and inflammation through targeting MAPKs/NF-κB/AP-1 signal pathways, suggesting the multi-targets of SO on RA treatment.